Genome editing with engineered nucleases, a powerful tool for understanding biological function and revealing causality, was built in a joint effort by academia and industry in 1994–2010. Use of CRISPR-Cas9 is the most recent (2013–), and facile, implementation of the resulting editing toolbox. Principles and methods of genome editing from the pre-CRISPR era remain relevant and continue to be useful.
Get full access to this article
View all access options for this article.
References
1.
RouetP, SmihF, JasinM. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol, 1994; 14:8096–8106.
2.
BibikovaM, CarrollD, SegalDJ, et al.Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol, 2001; 21:289–297. DOI: 10.1128/MCB.21.1.289-297.2001.
3.
BibikovaM, GolicM, GolicKG, et al.Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics, 2002; 161:1169–1175.
4.
BibikovaM, BeumerK, TrautmanJK, et al.Enhancing gene targeting with designed zinc finger nucleases. Science, 2003; 300:764–764. DOI: 10.1126/science.1079512.
5.
ClasenBM, StoddardTJ, LuoS, et al.Improving cold storage and processing traits in potato through targeted gene knockout. Plant Biotechnol J, 2016; 14:169–176. DOI: 10.1111/pbi.12370.
6.
TebasP, SteinD, TangWW, et al.Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med, 2014; 370:901–910. DOI: 10.1056/NEJMoa1300662.
UrnovFD, RebarEJ, HolmesMC, et al.Genome editing with engineered zinc finger nucleases. Nat Rev Genet, 2010; 11:636–646. DOI: 10.1038/nrg2842.
9.
CarrollD.Genome engineering with targetable nucleases. Annu Rev Biochem, 2014; 83:409–439. DOI: 10.1146/annurev-biochem-060713-035418.
10.
IshinoY, ShinagawaH, MakinoK, et al.Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol, 1987; 169:5429–5433.
11.
NakataA, AmemuraM, MakinoK.Unusual nucleotide arrangement with repeated sequences in the Escherichia coli K-12 chromosome. J Bacteriol, 1989; 171, 3553–3556.
12.
DoudnaJA, CharpentierE. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014; 346:125809–6. DOI: 10.1126/science.1258096.
13.
BarrangouR, HorvathP. A decade of discovery: CRISPR functions and applications. Nat Microbiol, 2017; 2:1709–2. DOI: 10.1038/nmicrobiol.2017.92.
14.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816–821. DOI: 10.1126/science.1225829.
15.
GasiunasG, BarrangouR, HorvathP, et al.Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A, 2012; 109:E2579–2586. DOI: 10.1073/pnas.1208507109.
16.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339:823–826. DOI: 10.1126/science.1232033.
17.
JinekM, EastA, ChengA, et al.RNA-programmed genome editing in human cells. Elife, 2, e00471 (2013). DOI: 10.7554/eLife.00471.
18.
ChoSW, KimS, KimJM, et al.Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol, 2013; 31:230–232. DOI: 10.1038/nbt.2507.
19.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823. DOI: 10.1126/science.1231143.
20.
CohenSN, ChangAC, BoyerHW, et al.Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A, 1973; 70:3240–3244.
21.
SangerF, NicklenS, CoulsonAR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A, 1977; 74:5463–5467.
22.
HinnenA, HicksJB, FinkGR. Transformation of yeast. Proc Natl Acad Sci U S A, 1978; 75:1929–1933.
23.
SchererS, DavisRW. Replacement of chromosome segments with altered DNA sequences constructed in vitro. Proc Natl Acad Sci U S A, 1979; 76:4951–4955.
24.
ThomasKR, FolgerKR, CapecchiMR. High frequency targeting of genes to specific sites in the mammalian genome. Cell, 1986; 44:419–428.
25.
RudnickiMA, BraunT, HinumaS, JaenischR. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell, 1992; 71:383–390.
26.
BrownJP, WeiW, SedivyJM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science, 1997; 277:831–834.
27.
HirataR, ChamberlainJ, DongR, et al.Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat Biotechnol, 2002; 20:735–738. DOI: 10.1038/nbt0702-735.
28.
KohliM, RagoC, LengauerC, et al.Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res, 2004; 32:e3. DOI: 10.1093/nar/gnh009.
29.
StrathernJN, KlarAJ, HicksJB, et al.Homothallic switching of yeast mating type cassettes is initiated by a double-stranded cut in the MAT locus. Cell, 1982; 31:183–192.
30.
HaberJE.A life investigating pathways that repair broken chromosomes. Annu Rev Genet, 2016; 50:1–28. DOI: 10.1146/annurev-genet-120215-035043.
31.
GallagherDN, HaberJE. Repair of a site-specific DNA cleavage: old-school lessons for Cas9-mediated gene editing. ACS Chem Biol, 2017Nov14 [Epub ahead of print]; DOI: 10.1021/acschembio.7b00760.
32.
SzostakJW, Orr-WeaverTL, RothsteinRJ, et al.The double-strand-break repair model for recombination. Cell, 1983; 33:25–35.
33.
JacquierA, DujonB. An intron-encoded protein is active in a gene conversion process that spreads an intron into a mitochondrial gene. Cell, 1985; 41:383–394.
34.
CrickFH, BarnettL, BrennerS, et al.General nature of the genetic code for proteins. Nature, 1961; 192:1227–1232.
35.
KimYG, ChaJ, ChandrasegaranS. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A, 1996; 93:1156–1160.
36.
AlmouzniG, WolffeAP. Nuclear assembly, structure, and function: the use of Xenopus in vitro systems. Exp Cell Res, 1993; 205:1–15.
37.
MillerJ, McLachlanAD, KlugA. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J, 1985; 4:1609–1614.
38.
TuplerR, PeriniG, GreenMR. Expressing the human genome. Nature, 2001; 409:832–833.
39.
KleppeK, OhtsukaE, KleppeR, et al.Studies on polynucleotides. XCVI. Repair replications of short synthetic DNA's as catalyzed by DNA polymerases. J Mol Biol, 1971; 56:341–361.
40.
SaikiRK, GelfandDH, StoffelS, et al.Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 1988; 239:487–491.
41.
MorganTH.Sex limited inheritance in Drosophila. Science, 1910; 32:120–122.
42.
UrnovFD, MillerJC, LeeYL, et al.Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature, 2005; 435:646–651. DOI: 10.1038/nature03556.
43.
Cavazzana-CalvoM, Hacein-BeyS, de Saint BasileG, et al.Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 2000; 288:669–672.
44.
Hacein-Bey-AbinaS, von KalleC, SchmidtM, et al.A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 2003; 348:255–256. DOI: 10.1056/NEJM200301163480314.
45.
PavletichNP, PaboCO. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science, 1991; 252:809–817.
46.
RebarEJ, PaboCO. Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science, 1994; 263:671–673.
47.
IsalanM, KlugA, ChooY. A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol, 2001; 19:656–660. DOI: 10.1038/90264.
48.
MoehleEA, RockJM, LeeYL, et al.Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci U S A, 2007; 104:3055–3060. DOI: 10.1073/pnas.0611478104.
49.
JiangJ, JingY, CostGJ, et al.Translating dosage compensation to trisomy 21. Nature, 2013; 500:296–300. DOI: 10.1038/nature12394.
50.
LombardoA, GenoveseP, BeausejourCM, et al.Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol, 2007; 25:1298–1306. DOI: 10.1038/nbt1353.
51.
OrlandoSJ, SantiagoY, DeKelverRC, et al.Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res, 2010; 38:e152–e152. DOI: 10.1093/nar/gkg512.
52.
ChenF, Pruett-MillerSM, HuangY, et al.High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods, 2011; 8:753–755. DOI: 10.1038/nmeth.1653.
53.
LiH, HaurigotV, DoyonY, et al.In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature, 2011; 475:217–221. DOI: 10.1038/nature10177.
54.
MarescaM, LinVG, GuoN, et al.Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res, 2013; 23:539–546. DOI: 10.1101/gr.145441.112.
55.
SantiagoY, ChanE, LiuPQ, et al.Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A, 2008; 105:5809–5814. DOI: 10.1073/pnas.0800940105.
56.
MaederML, Thibodeau-BegannyS, OsiakA, et al.Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell, 2008; 31:294–301. DOI: 10.1016/j.molcel.2008.06.016.
57.
PerezEE, WangJ, MillerJC, et al.Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol, 2008; 26:808–816. DOI: 10.1038/nbt1410.
58.
MaierDA, BrennanAL, JiangS, et al.Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5. Hum Gene Ther, 2013; 24:245–258. DOI: 10.1089/hum.2012.172.
59.
GabrielR, LombardoA, ArensA, et al.An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol, 2011; 29:816–823. DOI: 10.1038/nbt.1948.
60.
QasimW, ZhanH, SamarasingheS, et al.Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells. Sci Transl Med, 2017; 9. DOI: 10.1126/scitranslmed.aaj2013.
61.
HoltN, WangJ, KimK, et al.Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol, 2010; 28:839–847. DOI: 10.1038/nbt.1663.
62.
VierstraJ, ReikA, ChangKH, et al.Functional footprinting of regulatory DNA. Nat Methods, 2015; 12:927–930. DOI: 10.1038/nmeth.3554.
63.
ChangK-H, SmithSE, SullivanT, et al.Long-term engraftment and fetal globin induction upon BCL11A gene editing in bone-marrow-derived CD34+ hematopoietic stem and progenitor cells. Mol Ther, 2017; 4:137–148. DOI: 10.1016/j.omtm.2016.12.009.
64.
CanverMC, SmithEC, SherF, et al.BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature, 2015; 527:192–197. DOI: 10.1038/nature15521.
65.
PuchtaH, DujonB, HohnB. Homologous recombination in plant cells is enhanced by in vivo induction of double strand breaks into DNA by a site-specific endonuclease. Nucleic Acids Res, 1993; 21:5034–5040.
66.
DoyonY, McCammonJM, MillerJC, et al.Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol, 2008; 26:702–708. DOI: 10.1038/nbt1409.
67.
MengX, NoyesMB, ZhuLJ, et al.Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol, 2008; 26:695–701. DOI: 10.1038/nbt1398.
68.
GeurtsAM, CostGJ, FreyvertY, et al.Knockout rats via embryo microinjection of zinc-finger nucleases. Science, 2009; 325:433–433.
69.
ShuklaVK, DoyonY, MillerJC, et al.Precise genome modification in the crop species Zea mays using zinc-finger nucleases. Nature, 2009; 459:437–441. DOI: 10.1038/nature07992.
70.
TownsendJA, WrightDA, WinfreyRJ, et al.High-frequency modification of plant genes using engineered zinc-finger nucleases. Nature, 2009; 459:442–445.
71.
HwangWY, FuY, ReyonD, et al.Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol, 2013; 31:227–229. DOI: 10.1038/nbt.2501.
72.
TanW, CarlsonDF, LanctoCA, et al.Efficient nonmeiotic allele introgression in livestock using custom endonucleases. Proc Natl Acad Sci U S A, 2013; 110:16526–16531. DOI: 10.1073/pnas.1310478110.
73.
WoodAJ, LoTW, ZeitlerB, et al.Targeted genome editing across species using ZFNs and TALENs. Science, 2011; 333:30–7. DOI: 10.1126/science.1207773.
74.
YoungJJ, CheroneJM, DoyonY, et al.Efficient targeted gene disruption in the soma and germ line of the frog Xenopus tropicalis using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A, 2011; 108:7052–7057. DOI: 10.1073/pnas.1102030108.
75.
StraimerJ, LeeMC, LeeAH, et al.Site-specific genome editing in Plasmodium falciparum using engineered zinc-finger nucleases. Nat Methods, 2012; 9:993–998.
76.
DeGennaroM, McBrideCS, SeeholzerL, et al.orco mutant mosquitoes lose strong preference for humans and are not repelled by volatile DEET. Nature, 2013; 498:487–491. DOI: 10.1038/nature12206.
77.
MerlinC, BeaverLE, TaylorOR, et al.Efficient targeted mutagenesis in the monarch butterfly using zinc-finger nucleases. Genome Res, 2013; 23:159–168. DOI: 10.1101/gr.145599.112.
78.
HarelI, BenayounBA, MachadoB, et al.A platform for rapid exploration of aging and diseases in a naturally short-lived vertebrate. Cell, 2015; 160:1013–1026. DOI: 10.1016/j.cell.2015.01.038.
79.
YuJ, VodyanikMA, Smuga-OttoK, et al.Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007; 318:1917–1920. DOI: 10.1126/science.1151526.
80.
HockemeyerD, SoldnerF, BeardC, et al.Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol, 2009; 27:851–857. DOI: 10.1038/nbt.1562.
81.
ZouJ, MaederML, MaliP, et al.Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell, 2009; 5:97–110. DOI: 10.1016/j.stem.2009.05.023.
82.
SoldnerF, LaganièreJ, ChenAW, et al.Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell, 2011; 146:318–331. DOI: 10.1016/j.cell.2011.06.019.
83.
YusaK, RashidST, Strick-MarchandH, et al.Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature, 2011; 478:391–394. DOI: 10.1038/nature10424.
ChibaK, LorbeerFK, ShainAH, et al.Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science, 2017; 357:1416–1420. DOI: 10.1126/science.aao0535.
86.
VermaN, PanH, DoréLC, et al.TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat Genet, 2018; 50:83–95. DOI: 10.1038/s41588-017-0002-y.
87.
BochJ, ScholzeH, SchornackS, et al.Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 2009; 326:1509–1512. DOI: 10.1126/science.1178811.
88.
MoscouMJ, BogdanoveAJ. A simple cipher governs DNA recognition by TAL effectors. Science, 2009; 326:1501–1501. DOI: 10.1126/science.1178817.
89.
MillerJC, TanS, QiaoG, et al.A TALE nuclease architecture for efficient genome editing. Nat Biotechnol, 2011; 29:143–148. DOI: 10.1038/nbt.1755.
90.
CermakT, DoyleEL, ChristianM, et al.Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res, 2011; 39:e8–2. DOI: 10.1093/nar/gkr218.
91.
ReyonD, TsaiSQ, KhayterC, et al.FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol, 2012; 30:460–465. DOI: 10.1038/nbt.2170.
92.
MojicaFJ, Díez-VillasñeorC, García-MartínezJS, et al.Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol, 2005; 60:174–182. DOI: 10.1007/s00239-004-0046-3.
93.
BolotinA, QuinquisB, SorokinA, et al.Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology, 2005; 151:2551–2561. DOI: 10.1099/mic.0.28048-0.
94.
PourcelC, SalvignolG, VergnaudG. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology, 2005; 151:653–663. DOI: 10.1099/mic.0.27437-0.
95.
MakarovaKS, GrishinNV, ShabalinaSA, et al.A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct, 2006; 1:7. DOI: 10.1186/1745-6150-1-7.
96.
BarrangouR, FremauxC, DeveauH, et al.CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007; 315:1709–1712. DOI: 10.1126/science.1138140.
97.
MarraffiniLA, SontheimerEJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science, 2008; 322:1843–1845. DOI: 10.1126/science.1165771.
98.
BrounsSJJ, JoreMM, LundgrenM, et al.Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 2008; 321:960–964. DOI: 10.1126/science.1159689.
99.
GarneauJE, DupuisMÈ, VillionM, et al.The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 2010; 468:67–71. DOI: 10.1038/nature09523.
100.
DeltchevaE, ChylinskiK, SharmaCM, et al.CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 2011; 471:602–607. DOI: 10.1038/nature09886.
101.
GaudelliNM, KomorAC, ReesHA, et al.Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature, 2017; 551:464–471. DOI: 10.1038/nature24644.
102.
ThakorePI, BlackJB, HiltonIB, et al.Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods, 2016; 13:127–137. DOI: 10.1038/nmeth.3733.
103.
ElliottB, RichardsonC, WinderbaumJ, et al.Gene conversion tracts from double-strand break repair in mammalian cells. Mol Cell Biol, 1998; 18:93–101.
104.
LiangX, PotterJ, KumarS, et al.Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA. J Biotechnol, 2017; 241:136–146. DOI: 10.1016/j.jbiotec.2016.11.011.
105.
DeKelverRC, et al.Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res, 2010; 20:1133–1142. DOI: 10.1101/gr.106773.110.
106.
HockemeyerD, WangH, KianiS, et al.Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol, 2011; 29:731–734. DOI: 10.1038/nbt.1927.
107.
DoyonJB, ZeitlerB, ChengJ, et al.Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells. Nat Cell Biol, 2011; 13:331–337.
108.
LeeHJ, KimE, KimJ-S. Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res, 2010; 20:81–89. DOI: 10.1101/gr.099747.109.
109.
BrunetE, SimsekD, TomishimaM, et al.Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci U S A, 2009; 106:10620–10625. DOI: 10.1073/pnas.0902076106.
110.
MouH, SmithJL, PengL, et al.CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion. Genome Biol, 2017; 18:10–8. DOI: 10.1186/s13059-017-1237-8.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
